NDC product
Antibiotic Plus Pain Relief
NDC 11673-393 · TARGET Corporation
Key facts
| Product NDC | 11673-393 |
|---|---|
| Proprietary name | Antibiotic Plus Pain Relief |
| Nonproprietary name | Neomycin sulfate, Polymyxin B sulfate, and Pramoxine hydrochloride |
| Substances | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HYDROCHLORIDE |
| Dosage form | CREAM |
| Route | TOPICAL |
| Labeler | TARGET Corporation |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M017 |
| Pharmacologic classes | Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS] |
| Marketing start | Oct 16, 2020 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: